For people with
late-onset Pompe disease:
NEXVIAZYME is the first new enzyme replacement therapy for Pompe disease in 15 years. So now, for the first time, you have a choice. Ask your healthcare provider if NEXVIAZYME may be the right choice for you.Read the press release
WARNING: SEVERE HYPERSENSITIVITY REACTIONS, INFUSION-ASSOCIATED REACTIONS, AND RISK OF ACUTE CARDIORESPIRATORY FAILURE IN SUSCEPTIBLE PATIENTS
Hypersensitivity Reactions Including Anaphylaxis
If you are taking NEXVIAZYME, you should know that severe and potentially life-threatening allergic-type reactions known as anaphylaxis and severe hypersensitivity reactions may occur during and after NEXVIAZYME treatment. You should seek immediate medical care if signs and symptoms of anaphylaxis or hypersensitivity reactions occur. If such a reaction is severe enough, your doctor may decide to immediately discontinue the infusion and provide immediate medical care. Appropriate medical support measures may be administered during your infusion, and you may require close observation during and after NEXVIAZYME administration.
Infusion-Associated Reactions (IARs)
If severe IARs occur during your NEXVIAZYME infusion, your doctor may decide to immediately discontinue the infusion and provide appropriate medical care. If you have an acute underlying illness at the time of NEXVIAZYME infusion you may be at greater risk for IARs. If you have advanced Pompe disease you may have compromised heart and breathing function, which may put you at a higher risk of severe complications from IARs.
Risk of Acute Cardiorespiratory Failure in Susceptible Patients
If you are likely to develop fluid volume overload, or have acute underlying breathing problems or compromised heart or breathing function that may require fluid restriction, there may be a risk of worsening of your heart or breathing status during NEXVIAZYME infusion. Your doctor may decide that close observation during NEXVIAZYME administration may be necessary.
It’s always good to know how you’re doing on your current management plan. Our discussion guide can help you self-assess and prepare for your next conversation with your healthcare provider. This can be especially helpful if you’ve missed your regularly scheduled check-up due to Covid or concerns about Covid.
When you talk with your healthcare provider about changes you’ve noticed, goals and needs, you can ask if NEXVIAZYME can help you get where you want to be. Your healthcare provider can also help you understand what to expect with NEXVIAZYME.GET YOUR
Personalized support as you start NEXVIAZYME
If you’re already a member of CareConnectPSS®, you can keep the same dedicated Case Manager and Patient Education Liaison you’ve been working closely with already. They will continue to support you as you move to NEXVIAZYME and will help make the change a smooth one.
Whether you’re newly diagnosed, or starting treatment for the first time, it can be overwhelming. A member of the CareConnectPSS® team will be there to help you through each step. They offer a wide range of support services for you and your family that’s one-on-one, confidential, and personalized. Below is just some of what’s available to you.
Stay current on the latest news about Pompe disease and NEXVIAZYME by signing up to receive email updates from Sanofi Genzyme.
Call 1-800-745-4447, option 3, and talk to a CareConnectPSS® team member about signing up.
Complete the program application
Helpful information to have on hand when you apply:
- Your treating physician’s contact information
- Your health insurance card
Your eligibility is verified
Your application will be reviewed for eligibility. If you are eligible, you will be automatically enrolled in the program. Enrollment in the program is subject to confirmation.
Once approved, you will receive a confirmation letter and an enrollment card within 7-10 days. Contact
Case Manager if you do not receive this confirmation. Your healthcare provider or specialty pharmacy will also
phone call with instructions on how… read
claims for reimbursement through the program. Your enrollment in the program is effective
of approval through the end of the calendar year (calendar year is January 1 through December 31).
If you are currently enrolled in our Co-Pay Assistance Program you will be automatically enrolled in the program for the next calendar year (January 1 through December 31) unless you decide to opt out of the program or your insurance coverage changes and you are no longer eligible for the program. read less